Skip to content

Tyra Biosciences, Inc. TYRA Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$131.11M-36.0%-$119.95M-38.7%-$111.68M-33.4%-$105.83M-30.9%-$96.44M-27.8%
$541K+0.2%$546K+5.2%$558K+17.0%$554K+27.9%$540K+36.4%
$29.43M+17.2%$28.01M+22.8%$27.08M+33.5%$27.08M+58.4%$25.11M+65.1%
-$102.26M-39.7%-$95.14M-36.4%-$91.11M-43.0%-$86.63M-37.6%-$73.2M-17.5%
$215K-60.3%$141K-78.8%$90K-92.9%$103K-92.0%$542K-37.3%
$166.3M+4,048%$8.1M-96.0%$4.12M-98.0%$4.22M-97.9%$4.01M-98.0%
-$102.47M-38.9%-$95.28M-35.3%-$91.2M-40.4%-$86.73M-35.0%-$73.75M-16.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Tyra Biosciences, Inc. generate?
Tyra Biosciences, Inc. (TYRA) generated -$102.3M in operating cash flow over the trailing twelve months.
What is Tyra Biosciences, Inc.'s free cash flow?
After $215.0K of capital expenditures, Tyra Biosciences, Inc.'s free cash flow was -$102.5M over the trailing twelve months, down 39.0% year over year.
Where does Tyra Biosciences, Inc.'s cash flow data come from?
Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.